GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Probiotix Health PLC (AQSE:PBX) » Definitions » Net Income From Continuing Operations

Probiotix Health (AQSE:PBX) Net Income From Continuing Operations : £-0.43 Mil (TTM As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Probiotix Health Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Probiotix Health's net income from continuing operations for the six months ended in Jun. 2023 was £-0.51 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Jun. 2023 was £-0.43 Mil.

Probiotix Health Net Income From Continuing Operations Historical Data

The historical data trend for Probiotix Health's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Probiotix Health Net Income From Continuing Operations Chart

Probiotix Health Annual Data
Trend Dec18 Dec19 Dec20 Dec22
Net Income From Continuing Operations
- -0.45 -0.01 -0.23

Probiotix Health Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Jun22 Dec22 Jun23
Net Income From Continuing Operations Get a 7-Day Free Trial 0.12 0.05 -0.31 0.08 -0.51

Probiotix Health Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.43 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Probiotix Health (AQSE:PBX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Probiotix Health PLC (AQSE:PBX) » Definitions » Net Income From Continuing Operations
Comparable Companies
LSE:ROQ LSE:BSFA LSE:IMM LSE:OCTP LSE:CIZ LSE:IXI LSE:BVX LSE:APTA LSE:EVG AQSE:INC OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
X90:Germany
Address
Nostell Business Estate, First Floor Zucchi Suite, Wakefield, GBR, WF4 1AB
Website
https://www.probiotixhealth-ir.com
Probiotix Health PLC develops probiotics to tackle cardiovascular disease and other lifestyle conditions which are affecting growing numbers of people across the world. The Company has one class of business, in three geographical areas being that of identifying and developing microbial strains, compounds and formulations for use in the nutraceutical industry.

Probiotix Health (AQSE:PBX) Headlines

No Headlines